Tenax Therapeutics Inc (NASDAQ: TENX) stock fell -9.21% on Friday to $0.38 against a previous-day closing price of $0.42. With 5.67 million shares changed hands, the volume of the stock remained lighter than its average volume of 6.79 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.4079 whereas the lowest price it dropped to was $0.3410. The 52-week range on TENX shows that it touched its highest point at $4.30 and its lowest point at $0.15 during that stretch. It currently has a 1-year price target of $5.50. Beta for the stock currently stands at 2.64.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of TENX was up-trending over the past week, with a rise of 144.42%, but this was up by 30.14% over a month. Three-month performance dropped to -7.68% while six-month performance rose 23.04%. The stock lost -84.11% in the past year, while it has lost -82.89% so far this year. A look at the trailing 12-month EPS for TENX yields -1.40 with Next year EPS estimates of -0.34. For the next quarter, that number is -0.09. This implies an EPS growth rate of 95.46% for this year and 5.48% for next year.
Float and Shares Shorts:
At present, 23.86 million TENX shares are outstanding with a float of 23.27 million shares on hand for trading. On Oct 30, 2023, short shares totaled 18100.0, which was 0.08% higher than short shares on Sep 28, 2023. In addition to Mr. Christopher T. Giordano as the firm’s CEO, President & Director, Mr. Eliot M. Lurier CPA serves as its Interim Chief Financial Officer.
Through their ownership of 3.20% of TENX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 1.93% of TENX, in contrast to 0.53% held by mutual funds. As the largest shareholder in TENX with 0.80% of the stake, Corient Private Wealth LLC holds 191,460 shares worth 191,460. A second-largest stockholder of TENX, Geode Capital Management LLC, holds 118,978 shares, controlling over 0.50% of the firm’s shares. Two Sigma Securities LLC is the third largest shareholder in TENX, holding 97,037 shares or 0.41% stake. With a 0.49% stake in TENX, the Fidelity Extended Market Index Fu is the largest stakeholder. A total of 116,491 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.04% of TENX stock, is the second-largest Mutual Fund holder. It holds 8,691 shares valued at 1608.0. Fidelity Series Total Market Inde holds 0.00% of the stake in TENX, owning 966 shares worth 179.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for TENX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With TENX analysts setting a high price target of $6.00 and a low target of $5.00, the average target price over the next 12 months is $5.50. Based on these targets, TENX could surge 1478.95% to reach the target high and rise by 1215.79% to reach the target low. Reaching the average price target will result in a growth of 1347.37% from current levels.
Summary of Insider Activity:
Insiders traded TENX stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.